ArticleCurrent oncology (Toronto, Ont.)2025

Changes in HER2, ER, PR, and Ki-67 in HER2-Negative Breast Cancer After Neoadjuvant Chemotherapy: A Case-Control Study.

Youzhao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.